- Home
- MBI vs ORGO Comparison
MBI vs ORGO Comparison
Compare MBI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBI | ORGO |
|---|---|---|
| Founded | 1973 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.7M | 299.8M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MBI | ORGO |
|---|---|---|
| Price | $5.03 | $1.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.00 | ★ $8.50 |
| AVG Volume (30 Days) | 458.3K | ★ 885.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.04 | ★ 1600.00 |
| EPS | N/A | ★ N/A |
| Revenue | $80,000,000.00 | ★ $564,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 90.48 | 17.04 |
| 52 Week Low | $4.87 | $1.54 |
| 52 Week High | $8.26 | $7.08 |
Technical Indicators
Market Signals| Indicator | MBI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 47.59 |
| Support Level | N/A | $2.26 |
| Resistance Level | $6.30 | $2.63 |
| Average True Range (ATR) | 0.20 | 0.13 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 13.03 | 29.11 |
Price Performance
Historical ComparisonAbout MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. The U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiaries.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.